Table of Contents
Journal of Allergy
Volume 2011 (2011), Article ID 547389, 2 pages
http://dx.doi.org/10.1155/2011/547389
Case Report

Lability of IgE Levels Early in Life

Koffi N'guessan,1,2,3,4,5 David Ternant,2,3,4,6 François Labarthe,3,7,8 and Hervé Watier1,2,3,4

1Laboratoire d'Immunologie Faculté de Médecine, 10 Boulevard Tonnellé, 37032 Tours Cedex, France
2Pilot Center for Therapeutic Antibody Monitoring, CHRU de Tours, France
3Université François-Rabelais de Tours, France
4CNRS, UMR6239, France
5Faculté de Médecine d'Abidjan, Cote D'Ivoire
6Laboratories of Pharmacology, CHRU de Tours, France
7Pediatric Department, CHRU de Tours, France
8INSERM, U921, France

Received 21 February 2011; Accepted 28 April 2011

Academic Editor: Robert A. Wood

Copyright © 2011 Koffi N'guessan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Y. Siu, K. Tse, and Y. S. Lui, “Severe cow's milk protein allergy in a Chinese neonate,” Hong Kong Medical Journal, vol. 7, no. 4, pp. 442–444, 2001. View at Google Scholar · View at Scopus
  2. C. Rizk, L. Valdes, H. O. de Baulny, J. M. Saudubray, and C. Olivier, “Severe lactic acidosis disease disclosing milk-protein intolerance to cows' milk,” Archives of Pediatrics, vol. 6, no. 4, pp. 427–429, 1999. View at Google Scholar
  3. A. Erazo, N. Kutchukhidze, M. Leung et al., “Unique maturation program of the IgE response in vivo,” Immunity, vol. 26, no. 2, pp. 191–203, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. A. Dias, A. Santos, and J. A. Pinheiro, “Persistence of cow's milk allergy beyond two years of age,” Allergologia et Immunopathologia, vol. 38, no. 1, pp. 8–12, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Wyczółkowska, T. Michoń, T. Brzezińska-Błaszczyk, and C. Maśliński, “The relationship between specific IgE antibody and non-specific IgE in anaphylactic sensitization of mice and rats,” Archivum Immunologiae et Therapia Experimentalis, vol. 30, pp. 17–23, 1982. View at Google Scholar
  6. N. Hayashi, Y. Tsukamoto, W. M. Sallas, and P. J. Lowe, “A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab,” British Journal of Clinical Pharmacology, vol. 63, no. 5, pp. 548–561, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. E. Belnoue, M. Pihlgren, T. L. McGaha et al., “APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells,” Blood, vol. 111, no. 5, pp. 2755–2764, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus